⚖ Compare news

Put up to three stories side by side. Pick IDs from any article URL: /compare?id=123&id=456

Una vacuna diseñada para cada paciente logró reducir un 58% el riesgo de recaída en melanoma de alto riesgo

clarin.com ·Argentina · world
Words
29
Chars
169
AI summary
Yes
Full story

A new vaccine designed for individual patients has reduced the risk of relapse in high-risk melanoma by 58%. Each dose is created based on the unique footprint of the patient's tumor. Global trial data suggests this development is a turning point in oncological history.

Cada dosis se construye a partir de la huella única del tumor del paciente. Los datos del ensayo global son considerados un punto de inflexión en la historia oncológica.

Open article